


Healthcare News Roundup: FDA
HSMN NewsFeed - 28 Nov 2006
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
HSMN NewsFeed - 28 Nov 2006
St. Jude Medical Announces FDA Approval of Optim Lead Insulation for Cardiac Rhythm Management Therapy
St. Jude Medical Announces FDA Approval of Optim Lead Insulation for Cardiac Rhythm Management Therapy
HSMN NewsFeed - 27 Nov 2006
Otsuka Pharmaceutical Co., Ltd. Announces FDA Clearance for the RAPIRUN(R) H. pylori Antibody Detection Kit
Otsuka Pharmaceutical Co., Ltd. Announces FDA Clearance for the RAPIRUN(R) H. pylori Antibody Detection Kit
HSMN NewsFeed - 27 Nov 2006
Spectrum Dynamics Receives 510(K) Clearance for the D-SPECT(TM) Cardiac System
Spectrum Dynamics Receives 510(K) Clearance for the D-SPECT(TM) Cardiac System
HSMN NewsFeed - 27 Nov 2006
AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology
AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology
HSMN NewsFeed - 21 Nov 2006
US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
HSMN NewsFeed - 21 Nov 2006
Repligen Receives Orphan Drug Designation from the FDA for RG1068 for MRI Imaging of the Pancreas
Repligen Receives Orphan Drug Designation from the FDA for RG1068 for MRI Imaging of the Pancreas
HSMN NewsFeed - 17 Nov 2006
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
HSMN NewsFeed - 16 Nov 2006
The CoolTouch CTEV(TM) Endovenous Laser Now Approved to Treat Tributary Veins
The CoolTouch CTEV(TM) Endovenous Laser Now Approved to Treat Tributary Veins
HSMN NewsFeed - 16 Nov 2006
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
HSMN NewsFeed - 16 Nov 2006
EDDA Receives FDA Clearance for its IQQA(R)-Liver Software for Multiphase MDCT
EDDA Receives FDA Clearance for its IQQA(R)-Liver Software for Multiphase MDCT
HSMN NewsFeed - 15 Nov 2006
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic Melanoma
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic Melanoma
HSMN NewsFeed - 14 Nov 2006
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
HSMN NewsFeed - 14 Nov 2006
North American Scientific Announces FDA Clearance of its ClearPath(TM) HDR Breast Brachytherapy System
North American Scientific Announces FDA Clearance of its ClearPath(TM) HDR Breast Brachytherapy System
HSMN NewsFeed - 14 Nov 2006
Neoteric Technology Ltd. Receives U.S. FDA Marketing Clearance for Blood Management Products
Neoteric Technology Ltd. Receives U.S. FDA Marketing Clearance for Blood Management Products
HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
HSMN NewsFeed - 10 Nov 2006
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
HSMN NewsFeed - 10 Nov 2006
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
HSMN NewsFeed - 10 Nov 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
HSMN NewsFeed - 10 Nov 2006
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
HSMN NewsFeed - 9 Nov 2006
FDA Panel Unanimously Recommends Approval of Third Indication for Medtronic's INFUSE Bone Graft
FDA Panel Unanimously Recommends Approval of Third Indication for Medtronic's INFUSE Bone Graft
HSMN NewsFeed - 9 Nov 2006
Ascent Healthcare Receives 510(k) Clearance on Zimmer TransFx External Fixation Devices
Ascent Healthcare Receives 510(k) Clearance on Zimmer TransFx External Fixation Devices
HSMN NewsFeed - 9 Nov 2006
Kodak Submits Final Clinical Data to FDA for Approval of CR System for Mammography
Kodak Submits Final Clinical Data to FDA for Approval of CR System for Mammography
HSMN NewsFeed - 7 Nov 2006
St. Jude Medical Announces FDA Approval of New ICD Software for the Merlin(TM) Patient Care System
St. Jude Medical Announces FDA Approval of New ICD Software for the Merlin(TM) Patient Care System
HSMN NewsFeed - 6 Nov 2006
New Low Profile Optional Vena Cava Filter Receives Conditional FDA Approval to Begin U.S. Clinical Trial
New Low Profile Optional Vena Cava Filter Receives Conditional FDA Approval to Begin U.S. Clinical Trial
HSMN NewsFeed - 6 Nov 2006
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
HSMN NewsFeed - 3 Nov 2006
Boston Scientific Announces FDA Approval of NexStent(R) Carotid Artery Stenting System
Boston Scientific Announces FDA Approval of NexStent(R) Carotid Artery Stenting System
HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
HSMN NewsFeed - 2 Nov 2006
Gamida Cell's StemEx(R) Registration Study Receives Special Protocol Assessment from the FDA
Gamida Cell's StemEx(R) Registration Study Receives Special Protocol Assessment from the FDA
HSMN NewsFeed - 2 Nov 2006
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL
HSMN NewsFeed - 2 Nov 2006
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Submitted to FDA
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Submitted to FDA
HSMN NewsFeed - 31 Oct 2006
Cook Incorporated Receives FDA Approval for Breakthrough Endovascular Graft
Cook Incorporated Receives FDA Approval for Breakthrough Endovascular Graft
HSMN NewsFeed - 30 Oct 2006
Avantogen Oncology Inc. Announces FDA Acceptance Of Its IND For The Novel Cancer Drug Candidate, RP101
Avantogen Oncology Inc. Announces FDA Acceptance Of Its IND For The Novel Cancer Drug Candidate, RP101
HSMN NewsFeed - 27 Oct 2006
Elite Holds Clinical Guidance Meeting with the FDA on Its Abuse Deterrent Pain Program
Elite Holds Clinical Guidance Meeting with the FDA on Its Abuse Deterrent Pain Program
HSMN NewsFeed - 24 Oct 2006
BioLucent Receives FDA Clearance for SAVI, a New Breast Brachytherapy Device
BioLucent Receives FDA Clearance for SAVI, a New Breast Brachytherapy Device
HSMN NewsFeed - 24 Oct 2006
PLC Systems Receives FDA Permission to Begin RenalGuard(TM) Investigational Study
PLC Systems Receives FDA Permission to Begin RenalGuard(TM) Investigational Study
HSMN NewsFeed - 23 Oct 2006
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
HSMN NewsFeed - 23 Oct 2006
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
HSMN NewsFeed - 23 Oct 2006
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
HSMN NewsFeed - 20 Oct 2006
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
HSMN NewsFeed - 20 Oct 2006
AVONEX(R), The #1 Prescribed Multiple Sclerosis Therapy Worldwide, Improves Patient Convenience
AVONEX(R), The #1 Prescribed Multiple Sclerosis Therapy Worldwide, Improves Patient Convenience
HSMN NewsFeed - 20 Oct 2006
Siemens New Computer-Aided Detection Program Helps Physicians Detect More Lung Nodules
Siemens New Computer-Aided Detection Program Helps Physicians Detect More Lung Nodules
HSMN NewsFeed - 20 Oct 2006
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
HSMN NewsFeed - 19 Oct 2006
InfraReDx Announces FDA Clearance of its Near Infrared Spectroscopic System for Examining Coronary Arteries
InfraReDx Announces FDA Clearance of its Near Infrared Spectroscopic System for Examining Coronary Arteries
HSMN NewsFeed - 18 Oct 2006
Taxotere(R) Receives U.S. FDA Approval for the Treatment of Patients With Head and Neck Cancer
Taxotere(R) Receives U.S. FDA Approval for the Treatment of Patients With Head and Neck Cancer
HSMN NewsFeed - 17 Oct 2006
RITA Medical Systems Announces FDA 510(k) Clearance of HABIB 4X Laparoscopic(TM) Device
RITA Medical Systems Announces FDA 510(k) Clearance of HABIB 4X Laparoscopic(TM) Device
HSMN NewsFeed - 16 Oct 2006
CVRx(R), Inc., Receives IDE Approval for Rheos(TM) Baroreflex Hypertension Therapy(TM) System Pivotal Trial
CVRx(R), Inc., Receives IDE Approval for Rheos(TM) Baroreflex Hypertension Therapy(TM) System Pivotal Trial
HSMN NewsFeed - 16 Oct 2006
Pegasus Biologics Enters Wound Care Market With FDA Clearance for DermADAPT(TM) Biomatrix
Pegasus Biologics Enters Wound Care Market With FDA Clearance for DermADAPT(TM) Biomatrix
HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
HSMN NewsFeed - 13 Oct 2006
U.S. Food and Drug Administration Approves ARICEPT(R) for Treatment of Severe Alzheimer's Disease
U.S. Food and Drug Administration Approves ARICEPT(R) for Treatment of Severe Alzheimer's Disease
HSMN NewsFeed - 13 Oct 2006
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
HSMN NewsFeed - 12 Oct 2006
MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powder in UpTec(TM) for Oral Suspension
MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powder in UpTec(TM) for Oral Suspension
HSMN NewsFeed - 12 Oct 2006
TriPath Imaging Receives FDA 510(k) Clearance for p53 Application for Ventana Image Analysis System
TriPath Imaging Receives FDA 510(k) Clearance for p53 Application for Ventana Image Analysis System
HSMN NewsFeed - 12 Oct 2006
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
HSMN NewsFeed - 12 Oct 2006
Bovie Medical Corporation Announces FDA Clearance to Market New Laparoscopic Instruments
Bovie Medical Corporation Announces FDA Clearance to Market New Laparoscopic Instruments
HSMN NewsFeed - 12 Oct 2006
Anesiva Announces That FDA Grants Orphan Drug Status for Pain Drug 4975 to Treat Interdigital Neuroma
Anesiva Announces That FDA Grants Orphan Drug Status for Pain Drug 4975 to Treat Interdigital Neuroma
